Suchergebnisse - "Menzies-Gow, Andrew"

PubPharm (201)

1

Impact of sex on severe asthma : a cross-sectional retrospective analysis of UK primary and specialist care

enthalten in: Thorax | 2024

von Loewenthal, L. | Busby, J. | McDowell, R. | +20

2

Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Bourdin, A. | Brusselle, G. | Couillard, S. | +11

3

Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United Kingdom

enthalten in: The journal of allergy and clinical immunology. Global | 2024

von Tran, T. | Heatley, H. | Rowell, J. | +10

4

Biologic Therapy in Rare Eosinophil-Associated Disorders : Remaining Questions and Translational Research Opportunities

enthalten in: Journal of leukocyte biology | 2024

von Khoury, P. | Roufosse, F. | Kuang, F. | +83

5

Greenhouse gas emissions associated with suboptimal asthma care in the UK : the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study

enthalten in: Thorax | 2024

von Wilkinson, A. | Maslova, E. | Janson, C. | +7

6

Reply to "Exploring the long-term effects of biologic initiation in severe asthma : Insights from the International Severe Asthma Registry"

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Chen, W. | Tran, T. | Sadatsafavi, M. | +62

7

Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma

enthalten in: American journal of respiratory and critical care medicine | 2024

von Wechsler, M. | Scelo, G. | Larenas-Linnemann, D. | +83

CommentIn: Am J Respir Crit Care Med. 2024 Feb 1;209(3):233-235. - PMID 38064716

8

Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019 : A Population-Based, Serial Cross-Sectional Analysis

enthalten in: Pragmatic and observational research | 2024

von Menzies-Gow, A. | Tran, T. | Stanley, B. | +9

9

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL) : a randomised, multicentre, open-label, phase 4 study

enthalten in: Lancet (London, England) | 2024

von Jackson, D. | Heaney, L. | Humbert, M. | +41

ErratumIn: Lancet. 2024 Mar 23;403(10432):1140. - PMID 38521558

10

Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2024

von Scelo, G. | Torres-Duque, C. | Maspero, J. | +83

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]